MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 93 filers reported holding MEI PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -75.3% | 63,485 | +10.2% | 0.00% | -100.0% |
| Q4 2021 | $154,000 | -6.1% | 57,612 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $164,000 | -5.2% | 59,336 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $173,000 | -21.0% | 60,746 | -5.0% | 0.00% | 0.0% |
| Q1 2021 | $219,000 | +30.4% | 63,921 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $168,000 | -13.0% | 63,752 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $193,000 | -26.1% | 61,779 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $261,000 | +169.1% | 63,183 | +5.3% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | -11.0% | 59,983 | +36.0% | 0.00% | – |
| Q4 2019 | $109,000 | +51.4% | 44,089 | +2.5% | 0.00% | – |
| Q3 2019 | $72,000 | -33.9% | 43,032 | -0.7% | 0.00% | – |
| Q2 2019 | $109,000 | -99.9% | 43,332 | +428.2% | 0.00% | – |
| Q1 2014 | $91,299,000 | +42.4% | 8,203 | +2.5% | 0.00% | – |
| Q4 2013 | $64,128,000 | -12.2% | 8,006 | +24.3% | 0.00% | – |
| Q3 2013 | $73,030,000 | – | 6,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |